Herbert Faleck

719 total citations
14 papers, 477 citations indexed

About

Herbert Faleck is a scholar working on Neurology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Herbert Faleck has authored 14 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Herbert Faleck's work include Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Intracranial Aneurysms: Treatment and Complications (4 papers) and Cerebrospinal fluid and hydrocephalus (3 papers). Herbert Faleck is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Intracranial Aneurysms: Treatment and Complications (4 papers) and Cerebrospinal fluid and hydrocephalus (3 papers). Herbert Faleck collaborates with scholars based in United States, Germany and Canada. Herbert Faleck's co-authors include Jerome B. Zeldis, Donald C. Manning, Elyse E. Lower, Stewart B. Fleishman, Zhinuan Yu, Nima Etminan, Daniel Hänggi, Stephan A. Mayer, Michael N. Diringer and R. Loch Macdonald and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

Herbert Faleck

14 papers receiving 453 citations

Peers

Countries citing papers authored by Herbert Faleck

Since Specialization

Citations

This map shows the geographic impact of Herbert Faleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Faleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Faleck more than expected).

Fields of papers citing papers by Herbert Faleck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Faleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Faleck. The network helps show where Herbert Faleck may publish in the future.

Co-authorship network of co-authors of Herbert Faleck

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Faleck. A scholar is included among the top collaborators of Herbert Faleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Faleck. Herbert Faleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Nimodipine pharmacokinetics after intraventricular injection of sustained-release nimodipine for subarachnoid hemorrhage 2019 ·Journal of neurosurgery ·R. Loch Macdonald, Daniel Hänggi, Poul Strange, Hans Jakob Steiger, J Mocco, Michael M. Miller, Stephan A. Mayer, Brian L. Hoh, Herbert Faleck, Nima Etminan, Michael N. Diringer, Andrew P. Carlson, François Aldrich, (unknown)	10
2	Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)] 2018 ·Neurocritical Care ·Daniel Hänggi, Nima Etminan, Stephan A. Mayer, E. François Aldrich, Michael N. Diringer, Erich Schmutzhard, Herbert Faleck, David Ng, Benjamin R. Saville, R. Loch Macdonald, (unknown)	23
3	A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage 2016 ·Neurotherapeutics ·Daniel Hänggi, Nima Etminan, Hans Jakob Steiger, Mark D. Johnson, M. Melissa Peet, (unknown), Kevin W. Burton, Bruce S. Hudson, (unknown), (unknown), (unknown), (unknown), Herbert Faleck, R. Loch Macdonald	13
4	Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]) 2016 ·Stroke ·Daniel Hänggi, Nima Etminan, François Aldrich, Hans Jakob Steiger, Stephan A. Mayer, Michael N. Diringer, Brian L. Hoh, J Mocco, Herbert Faleck, R. Loch Macdonald	44
5	NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage 2015 ·Neurocritical Care ·Daniel Hänggi, Nima Etminan, R. Loch Macdonald, Hans Jakob Steiger, Stephan A. Mayer, François Aldrich, Michael N. Diringer, Brian L. Hoh, J Mocco, Poul Strange, Herbert Faleck, Michael M. Miller	42
6	Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease 2013 ·Inflammatory Bowel Diseases ·Lloyd Mayer, William M. Pandak, Gil Melmed, Stephen B. Hanauer, Kristine Johnson, (unknown), Herbert Faleck, Robert Hariri, Steven Fischkoff	57
7	Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone 2010 ·Stem Cells ·Xin Li, Wen Ling, Angela Pennisi, Yuping Wang, Sharmin Khan, Mohammad A. Heidaran, Ajai Pal, Xiaokui Zhang, (unknown), (unknown), Stewart Abbot, Herbert Faleck, Robert Hariri, John D. Shaughnessy, Frits van Rhee, Bijay Nair, Bart Barlogie, Joshua Epstein, Shmuel Yaccoby	67
8	Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial 2009 ·Journal of Pain and Symptom Management ·Elyse E. Lower, Stewart B. Fleishman, (unknown), Jerome B. Zeldis, Herbert Faleck, Zhinuan Yu, Donald C. Manning	137
9	A Multicenter, Single-Arm, Open-Label Study To Evaluate the Efficacy and Safety of Single-Agent Lenalidomide in Patients with Relapsed and Refractory Multiple Myeloma; Prelininary Results. 2005 ·Blood ·Paul G. Richardson, Sundar Jagannath, Mohamad A. Hussein, James R. Berenson, Seema Singhal, David Irwin, Stephanie Williams, William Bensinger, Ashraf Badros, Robert Vescio, Laurie Kenvin, Zhinuan Yu, Marta Olesnyckyj, Herbert Faleck, Jerome B. Zeldis, Robert Knight, Kenneth C. Anderson	20
10	A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and “chemobrain” in adult cancer patients 2005 ·Journal of Clinical Oncology ·Elyse E. Lower, Stewart B. Fleishman, (unknown), Jerome B. Zeldis, Herbert Faleck, Donald C. Manning	25
11	Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder 2004 ·Journal of Child and Adolescent Psychopharmacology ·Raul Silva, (unknown), (unknown), Sharon Kowalik, Vikram Khetani, Herbert Faleck, John Patin	13
12	Response of CSF IgG to steroids in an 18-month-old with chronic inflammatory polyradiculoneuropathy 1989 ·Cleveland Clinic Journal of Medicine ·Herbert Faleck, Robert P. Cruse, Kerry H. Levin, Melinda L. Estes	6
13	A 29-year-old woman with back pain and a lumbar mass 1988 ·Cleveland Clinic Journal of Medicine ·Melinda L. Estes, Robert J. Lederman, Srinivasan Vijayakumar, Russell W. Hardy, Herbert Faleck, (unknown)	2
14	Headache and Subacute Sinusiris in Children and Adolescents 1988 ·Headache The Journal of Head and Face Pain ·Herbert Faleck, A. David Rothner, Gerald Erenberg, Robert P. Cruse	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact